Skip to main content

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value Creation Proposed Combination Would Deploy Nano Dimension’s Capital Base and Nasdaq listing into a High-Growth Healthcare AI Opportunity Existing Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension’s Shares that Reflects a 20% Premium to Nano Dimension’s Estimated Net Cash at Closing Infinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disease States, Combining One of the Largest Private Epigenetic Datasets with a Proprietary Biological AI Platform to Provide Earlier Warning of Disease...

Continue reading

Vireo Growth Inc. and C21 Investments Inc. Announce Definitive Arrangement Agreement

Acquisition will expand Vireo’s operating footprint in the Nevada market with 3 leading dispensaries and approximately 104,000 sq. ft. of cultivation and production capacity MINNEAPOLIS and VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) — Vireo Growth Inc. (CSE: VREO; OTCQX: VREOD) (“Vireo”), a multi-state cannabis operator, and C21 Investments Inc. (CSE: CXXI; OTCQX: CXXIF) (“C21”), a vertically-integrated cannabis company, today announced that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant to which Vireo will acquire all of the issued and outstanding common shares of C21 (after conversion of all subordinate voting shares of C21) (the “C21 Shares”) in exchange for Vireo Shares (as defined below) (the “Transaction”). Pursuant to the terms of the Arrangement Agreement,...

Continue reading

Natural Gas Services Group Acquires Flatrock Compression

$120 million cash and stock acquisition is immediately and materially accretive Diversifies NGS’s customer mix while adding multiple new large customers Strategic acquisition deepens NGS’s operational footprint across the Permian Basin and Eagle Ford Significantly expands the Company’s large horsepower and electric motor driven compression solutions Existing credit facility increased to $500 million in conjunction with acquisition NGS to host a conference call on Monday, June 15, 2026, at 10:00 a.m. Eastern TimeSOUTHLAKE, Texas, June 15, 2026 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE: NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced that it has acquired Flatrock Compression Holdings...

Continue reading

Schouw & Co. share buy-back programme, week 24 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 5 June 2026 144,283 667.55 96,315,710    Monday, 8 June 2026 1,000 635.50 635,500    Tuesday, 9 June 2026 1,000 631.73 631,734    Wednesday, 10 June 2026 1,000 624.00 624,000    Thursday, 11 June 2026 1,000 625.55 625,552    Friday,...

Continue reading

IREN Completes Acquisition of Nostrum Group Expanding AI Cloud Platform to Europe

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced it has completed the acquisition of Ingenostrum, S.L. (Nostrum Group), a developer of grid-connected AI data centers based in Spain. The acquisition marks IREN’s entry into the European market, adding approximately 490MW of secured, grid-connected power in Spain and an additional development pipeline. Nostrum also brings a team of more than 50 people across development, engineering, construction and operations. The acquisition establishes a strong foundation for IREN to serve rapidly growing AI Cloud demand across Europe, one of the largest and fastest growing markets. Nostrum’s operations will continue under the IREN brand. Daniel Roberts, Co-Founder and Co-CEO of IREN, said: “Europe is one of the largest and fastest-growing markets...

Continue reading

Andrew Peller Enters into Definitive Agreement to be Acquired by Fairfax

Shareholders to Receive $8.00 per Class A Share and $12.00 per Class B Share $8.00 per Class A Share represents a 41% and 42% premium to the closing price and 20-day VWAP of Andrew Peller’s Class A Shares on the TSX as of June 12, 2026 $12.00 per Class B Share represents a 70% and 66% premium to the closing price and 20-day VWAP of Andrew Peller’s Class B Shares on the TSX as of June 12, 2026 All-cash offer crystallizes value for all Andrew Peller Shareholders, offering certainty of value and liquidity Voting support agreements have been entered into with the Company’s two largest shareholders and Directors and Officers, representing approximately 20% Class A Shares and approximately 75% Class B Shares John Peller and his affiliate entities have agreed to exchange all their Shares for shares of the Purchaser Andrew Peller’s Board and...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 12 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 12 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Banqup Group Announces Strategic Simplification Plan and Launch of Process to Explore Strategic Alternatives

La Hulpe, Belgium – 15 June 2026, 7:00 a.m. CET – INSIDE INFORMATION – Banqup Group SA (Euronext Brussels: BANQ) (“Banqup” or the “Company”) today announces that, following an extensive review, the Board has approved a strategic simplification plan to reorganize the Group into distinct, autonomous business units to enhance operational focus and transparency. Lazard is mandated to explore all strategic options, including the sale of individual business units or the Group as a whole in order to maximize stakeholder value. Strategic review and conclusions Over the past eight months, the Board commissioned Lazard to conduct a strategic review of the Company’s strategic positioning, capital structure and long-term value creation opportunities. The review confirmed the strength of Banqup’s core businesses and highlighted the...

Continue reading

Lotus Tech Announces Operational and Earnings Reporting Updates

Lotus Tech is advancing the strategic acquisition of Lotus UK targeted to close in 2026, to unify brand positioning and improve operational efficiency. Comprehensive pre-acquisition and integration planning is in progress to unlock full synergies and support the execution of the Company’s Focus 2030 long-term strategy. The Company temporarily suspends the release of financial results for the first and third quarters in 2026 to prioritize acquisition- related compliance work.NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today provided an update on recent developments and announced the temporary suspension of the publication of earnings releases for the first quarter and third quarter of fiscal year 2026. Recent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.